1. Home
  2. OCUL vs JKS Comparison

OCUL vs JKS Comparison

Compare OCUL & JKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • JKS
  • Stock Information
  • Founded
  • OCUL 2006
  • JKS 2006
  • Country
  • OCUL United States
  • JKS China
  • Employees
  • OCUL N/A
  • JKS N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • JKS Semiconductors
  • Sector
  • OCUL Health Care
  • JKS Technology
  • Exchange
  • OCUL Nasdaq
  • JKS Nasdaq
  • Market Cap
  • OCUL 1.2B
  • JKS 1.4B
  • IPO Year
  • OCUL 2014
  • JKS 2010
  • Fundamental
  • Price
  • OCUL $7.00
  • JKS $23.04
  • Analyst Decision
  • OCUL Strong Buy
  • JKS Hold
  • Analyst Count
  • OCUL 7
  • JKS 5
  • Target Price
  • OCUL $16.71
  • JKS $28.79
  • AVG Volume (30 Days)
  • OCUL 917.6K
  • JKS 590.5K
  • Earning Date
  • OCUL 03-10-2025
  • JKS 03-19-2025
  • Dividend Yield
  • OCUL N/A
  • JKS 12.73%
  • EPS Growth
  • OCUL N/A
  • JKS N/A
  • EPS
  • OCUL N/A
  • JKS 0.89
  • Revenue
  • OCUL $61,442,000.00
  • JKS $14,888,551,409.00
  • Revenue This Year
  • OCUL $11.40
  • JKS N/A
  • Revenue Next Year
  • OCUL $13.58
  • JKS $11.12
  • P/E Ratio
  • OCUL N/A
  • JKS $26.75
  • Revenue Growth
  • OCUL 6.45
  • JKS N/A
  • 52 Week Low
  • OCUL $4.06
  • JKS $16.70
  • 52 Week High
  • OCUL $11.78
  • JKS $37.36
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 31.92
  • JKS 54.55
  • Support Level
  • OCUL $7.14
  • JKS $21.31
  • Resistance Level
  • OCUL $7.42
  • JKS $23.13
  • Average True Range (ATR)
  • OCUL 0.37
  • JKS 1.01
  • MACD
  • OCUL -0.02
  • JKS 0.42
  • Stochastic Oscillator
  • OCUL 0.76
  • JKS 74.50

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About JKS JinkoSolar Holding Company Limited (each representing 4)

JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), North America, Europe, Asia Pacific (except China, which includes Hong Kong and Taiwan), and the Rest of the world.

Share on Social Networks: